Dov Elefant

Controller- VP Finance & Admin, IMMUNE PHARMACEUTICALS INC.

Companies

FEMASYS INCChief financial officer Mar 1, 2022 to now¹
Cellectar Biosciences, Inc.Chief financial officer Sep 11, 2019 to Jan 27, 2022²
Akari Therapeutics PlcChief financial officer Jan 2, 2015 to Sep 22, 2015³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

FEMASYS INC FEMY15,625 shares⁴$25.8K at $1.65Aug 7, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 7, 2026Bought 15,625 shares at $3.20 of FEMASYS INC⁴
Aug 27, 2025I 38,828 shares of FEMASYS INC⁵
Jun 2, 2025I 19,608 shares at $1.02 of FEMASYS INC⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARFEMASYS INC, Chief financial officer
2
SEC EDGARCellectar Biosciences, Inc., Chief financial officer
3
SEC EDGARAkari Therapeutics Plc, Chief financial officer
4
SEC EDGARFEMASYS INC shares after the filing of Aug 7, 2026
5
SEC EDGARForm 4 filed Aug 28, 2025
6
SEC EDGARForm 4 filed Jun 4, 2025